Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

More Big Phar­mas and hot­ly-watched biotechs have dis­closed the to­tal com­pen­sa­tion fig­ures for their ex­ec­u­tives, high­light­ing the pay pack­ages of Covid-19 be­he­moths, in­sulin mak­ers and rare dis­ease drug de­vel­op­ers.

Pfiz­er CEO Al­bert Bourla brought in $33.01 mil­lion, Mod­er­na’s Stéphane Ban­cel racked up $19.36 mil­lion, Eli Lil­ly’s Dave Ricks lined up $21.398 mil­lion, Sanofi’s Paul Hud­son snagged €10.718 mil­lion (about $11.38 mil­lion), John­son & John­son’s Joaquin Du­a­to made $13.09 mil­lion, and the leader of Hori­zon Ther­a­peu­tics, Tim Wal­bert, nabbed $20.1 mil­lion last year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER